Burden of kidney cancer in China from 1990 to 2021 and predictions for 2036: an age-period-cohort analysis of global burden of disease study 2021

Abstract Objective This study aimed to describe the temporal trends and risk factors of kidney cancer (KC) burden from 1990 to 2021, evaluate its age, period, and cohort effects, and project the disease burden over the next 15 years. Methods Data were derived from the 2021 Global Burden of Disease (...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi-Fan Zhang, Yun-Hua Ji, Hao-Zhong Hou, Xiao-Zheng Fan, Bo Yang, Zhen Yao, Hao Wang, Bo Zhang, Long-Long Zhang, Xiao-Jian Yang
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-025-23476-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238366390845440
author Yi-Fan Zhang
Yun-Hua Ji
Hao-Zhong Hou
Xiao-Zheng Fan
Bo Yang
Zhen Yao
Hao Wang
Bo Zhang
Long-Long Zhang
Xiao-Jian Yang
author_facet Yi-Fan Zhang
Yun-Hua Ji
Hao-Zhong Hou
Xiao-Zheng Fan
Bo Yang
Zhen Yao
Hao Wang
Bo Zhang
Long-Long Zhang
Xiao-Jian Yang
author_sort Yi-Fan Zhang
collection DOAJ
description Abstract Objective This study aimed to describe the temporal trends and risk factors of kidney cancer (KC) burden from 1990 to 2021, evaluate its age, period, and cohort effects, and project the disease burden over the next 15 years. Methods Data were derived from the 2021 Global Burden of Disease (GBD) study. A joinpoint regression model was used to estimate the average annual percentage change (AAPC) in KC prevalence and mortality, while age-period-cohort analysis was applied to estimate age, period, and cohort effects. We extended the Bayesian age-period-cohort (BAPC) model to predict the disease burden of KC from 2022 to 2036. Results In 2021, the number of incident KC cases in China reached 65,799 (4.62 cases per 100,000 total population). Additionally, KC resulted in 24,867 deaths (1.75 deaths per 100,000 total population).The incidence rate of KC continued to rise from 1.38 per 100,000 in 1990 to 4.62 per 100,000 in 2021, with males consistently exceeding females in case numbers. Meanwhile, KC mortality rose from 0.77 per 100,000 in 1990 to 1.75 per 100,000 in 2021.Throughout the study period, the average annual percent changes (AAPC) in incidence and mortality were 3.92% and 2.61%, respectively. Males exhibited higher prevalence and mortality of KC. In the Age-Period-Cohort (APC) analysis, the risk of KC was observed to increase with advancing age in the age dimension. Period effects analysis revealed an overall downward trajectory in all age groups. Cohort-level analysis indicated that early birth cohorts had higher susceptibility, with those born before 1920–1925 exhibiting a higher risk profile that subsequently decreased over time. Smoking and high body mass index (BMI) were the primary risk factors for KC-related disability-adjusted life years (DALYs) and mortality, while the contribution of occupational exposure to trichloroethylene was relatively minor. By 2036, the age-standardized incidence and mortality of KC are projected to rise to 4.58 and 1.31 per 100,000, respectively. Conclusion To alleviate the disease burden of KC, comprehensive strategies are required, including risk factor prevention in primary care settings, KC screening for the elderly and high-risk populations, and access to high-quality medical services.
format Article
id doaj-art-746e71f5552d4e4b9b8bba7c2c257b75
institution Kabale University
issn 1471-2458
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj-art-746e71f5552d4e4b9b8bba7c2c257b752025-08-20T04:01:40ZengBMCBMC Public Health1471-24582025-07-0125111010.1186/s12889-025-23476-8Burden of kidney cancer in China from 1990 to 2021 and predictions for 2036: an age-period-cohort analysis of global burden of disease study 2021Yi-Fan Zhang0Yun-Hua Ji1Hao-Zhong Hou2Xiao-Zheng Fan3Bo Yang4Zhen Yao5Hao Wang6Bo Zhang7Long-Long Zhang8Xiao-Jian Yang9Department of Urology, Xijing Hospital, Air Force Military Medical UniversityDepartment of Urology, Tangdu Hospital, Air Force Military Medical UniversityDepartment of Urology, Tangdu Hospital, Air Force Military Medical UniversityDepartment of Urology, Xijing Hospital, Air Force Military Medical UniversityDepartment of Urology, Xijing Hospital, Air Force Military Medical UniversityDepartment of Urology, Tangdu Hospital, Air Force Military Medical UniversityDepartment of Urology, Tongji Shanxi Hospital, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical UniversityDepartment of Urology, Tangdu Hospital, Air Force Military Medical UniversityDepartment of Urology, Xijing Hospital, Air Force Military Medical UniversityDepartment of Urology, Xijing Hospital, Air Force Military Medical UniversityAbstract Objective This study aimed to describe the temporal trends and risk factors of kidney cancer (KC) burden from 1990 to 2021, evaluate its age, period, and cohort effects, and project the disease burden over the next 15 years. Methods Data were derived from the 2021 Global Burden of Disease (GBD) study. A joinpoint regression model was used to estimate the average annual percentage change (AAPC) in KC prevalence and mortality, while age-period-cohort analysis was applied to estimate age, period, and cohort effects. We extended the Bayesian age-period-cohort (BAPC) model to predict the disease burden of KC from 2022 to 2036. Results In 2021, the number of incident KC cases in China reached 65,799 (4.62 cases per 100,000 total population). Additionally, KC resulted in 24,867 deaths (1.75 deaths per 100,000 total population).The incidence rate of KC continued to rise from 1.38 per 100,000 in 1990 to 4.62 per 100,000 in 2021, with males consistently exceeding females in case numbers. Meanwhile, KC mortality rose from 0.77 per 100,000 in 1990 to 1.75 per 100,000 in 2021.Throughout the study period, the average annual percent changes (AAPC) in incidence and mortality were 3.92% and 2.61%, respectively. Males exhibited higher prevalence and mortality of KC. In the Age-Period-Cohort (APC) analysis, the risk of KC was observed to increase with advancing age in the age dimension. Period effects analysis revealed an overall downward trajectory in all age groups. Cohort-level analysis indicated that early birth cohorts had higher susceptibility, with those born before 1920–1925 exhibiting a higher risk profile that subsequently decreased over time. Smoking and high body mass index (BMI) were the primary risk factors for KC-related disability-adjusted life years (DALYs) and mortality, while the contribution of occupational exposure to trichloroethylene was relatively minor. By 2036, the age-standardized incidence and mortality of KC are projected to rise to 4.58 and 1.31 per 100,000, respectively. Conclusion To alleviate the disease burden of KC, comprehensive strategies are required, including risk factor prevention in primary care settings, KC screening for the elderly and high-risk populations, and access to high-quality medical services.https://doi.org/10.1186/s12889-025-23476-8Kidney cancerAge-period-cohort analysisBayesian age–period–cohortJoin-point regression
spellingShingle Yi-Fan Zhang
Yun-Hua Ji
Hao-Zhong Hou
Xiao-Zheng Fan
Bo Yang
Zhen Yao
Hao Wang
Bo Zhang
Long-Long Zhang
Xiao-Jian Yang
Burden of kidney cancer in China from 1990 to 2021 and predictions for 2036: an age-period-cohort analysis of global burden of disease study 2021
BMC Public Health
Kidney cancer
Age-period-cohort analysis
Bayesian age–period–cohort
Join-point regression
title Burden of kidney cancer in China from 1990 to 2021 and predictions for 2036: an age-period-cohort analysis of global burden of disease study 2021
title_full Burden of kidney cancer in China from 1990 to 2021 and predictions for 2036: an age-period-cohort analysis of global burden of disease study 2021
title_fullStr Burden of kidney cancer in China from 1990 to 2021 and predictions for 2036: an age-period-cohort analysis of global burden of disease study 2021
title_full_unstemmed Burden of kidney cancer in China from 1990 to 2021 and predictions for 2036: an age-period-cohort analysis of global burden of disease study 2021
title_short Burden of kidney cancer in China from 1990 to 2021 and predictions for 2036: an age-period-cohort analysis of global burden of disease study 2021
title_sort burden of kidney cancer in china from 1990 to 2021 and predictions for 2036 an age period cohort analysis of global burden of disease study 2021
topic Kidney cancer
Age-period-cohort analysis
Bayesian age–period–cohort
Join-point regression
url https://doi.org/10.1186/s12889-025-23476-8
work_keys_str_mv AT yifanzhang burdenofkidneycancerinchinafrom1990to2021andpredictionsfor2036anageperiodcohortanalysisofglobalburdenofdiseasestudy2021
AT yunhuaji burdenofkidneycancerinchinafrom1990to2021andpredictionsfor2036anageperiodcohortanalysisofglobalburdenofdiseasestudy2021
AT haozhonghou burdenofkidneycancerinchinafrom1990to2021andpredictionsfor2036anageperiodcohortanalysisofglobalburdenofdiseasestudy2021
AT xiaozhengfan burdenofkidneycancerinchinafrom1990to2021andpredictionsfor2036anageperiodcohortanalysisofglobalburdenofdiseasestudy2021
AT boyang burdenofkidneycancerinchinafrom1990to2021andpredictionsfor2036anageperiodcohortanalysisofglobalburdenofdiseasestudy2021
AT zhenyao burdenofkidneycancerinchinafrom1990to2021andpredictionsfor2036anageperiodcohortanalysisofglobalburdenofdiseasestudy2021
AT haowang burdenofkidneycancerinchinafrom1990to2021andpredictionsfor2036anageperiodcohortanalysisofglobalburdenofdiseasestudy2021
AT bozhang burdenofkidneycancerinchinafrom1990to2021andpredictionsfor2036anageperiodcohortanalysisofglobalburdenofdiseasestudy2021
AT longlongzhang burdenofkidneycancerinchinafrom1990to2021andpredictionsfor2036anageperiodcohortanalysisofglobalburdenofdiseasestudy2021
AT xiaojianyang burdenofkidneycancerinchinafrom1990to2021andpredictionsfor2036anageperiodcohortanalysisofglobalburdenofdiseasestudy2021